Zepp Health revenue surges 43% as gross margins hit record 40%
Zepp Health (NYSE:ZEPP) reported a 43% year-over-year increase in fourth-quarter revenue, reaching $85.2 million and meeting the high end of its previous guidance.
United Statesmtc
US Is 'Wrong' to Defund mRNA Research, WHO Chief Says
World Health Organization Chief Tedros Adhanom Ghebreyesus speaks to Bloomberg's Mishal Husain about the US stance on mRNA vaccine research funding. "I hope they will reconsider," he says on The Mishal Husain Show. He also talks about his relationship with US Health Secretary Robert F. Kennedy Jr., saying they "continue to speak to each other."